News
Men must exercise nearly twice as long as women to achieve the same 30 per cent reduction in heart disease risk, according to new research. Women who exercised for 250 minutes a week saw their coronary heart disease risk fall by 30 per cent, while men needed about 530 minutes — nearly nine hours — [...]
Older adults who frequently engage with music may have up to a 39 per cent lower risk of developing dementia, according to new research. Regularly playing an instrument was linked to a 35 per cent reduced risk, while those who both listened to and played music showed a 33 per cent lower risk. The findings [...]
AlayaCare has acquired Nightingale Software to expand its aged care footprint in Australia and New Zealand, pending customary conditions and regulatory approvals. AlayaCare Nightingale’s platform will continue to operate and staff will be retained, with services supported by AlayaCare’s technology, product roadmap and resources. The company says its all-in-one platform offers real-time data insights, personalised [...]
The UK government has announced a plan to diagnose 92 per cent of people with dementia within 18 weeks of a doctor’s referral by 2029 — up from fewer than half today. A £5m research challenge will fund new diagnostic tools, including blood tests, saliva analysis and AI-driven technologies, to speed up detection and improve [...]
US adults scored an average of 60 out of 100 on the new Longevity Preparedness Index (LPI), indicating that most are underprepared to live well as they age. The index measures readiness across eight areas: social connection, daily activities, care, home, community, life transitions, health and finance. Care preparedness scored lowest at 42, while community [...]
Czech company H₂ Medical Technologies, a subsidiary of H₂ Global Group, has received official approval from the State Institute for Drug Control (SÚKL) to begin a clinical study on molecular hydrogen inhalation therapy for patients with mild cognitive impairment (MCI), an early stage of Alzheimer’s disease. The authorisation marks Europe’s first fully approved clinical trial [...]
Canada has conditionally approved Leqembi (lecanemab), the first treatment that targets an underlying cause of early Alzheimer’s disease by removing toxic amyloid beta proteins from the brain. Health Canada issued the Notice of Compliance with Conditions on 27 October for adults with mild cognitive impairment or mild dementia due to Alzheimer’s disease who have confirmed [...]
Swapping just 30 minutes of sitting for light activity, such as walking or housework, can improve mood and energy the following day, new research suggests. A study involving more than 350 young adults found that on days when participants spent less time sitting and more time doing light activity, they felt happier and more energised [...]
Bright light at night raises the risk of heart attack by 47 per cent and heart failure by 56 per cent, according to research involving nearly 89,000 people. Being exposed to bright light at night could significantly increase the chances of developing serious heart problems, including heart attacks, strokes and heart failure. The largest study [...]
Generation Lab has raised US$11m to expand its SystemAge platform for ageing diagnostics and clinic rollout, less than a year after launch. The seed round, led by Accel, brings total funding to US$15m. Other backers include Samsung Next, Zone2, Aoki Labs, BYL Ventures and Markham Valley Ventures. SystemAge estimates biological age — how well body [...]
